- Home
- PTGX vs HTH Comparison
PTGX vs HTH Comparison
Compare PTGX & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | HTH |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 2.2B |
| IPO Year | 2016 | 2003 |
Fundamental Metrics
Financial Performance| Metric | PTGX | HTH |
|---|---|---|
| Price | $142.25 | $38.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $108.23 | $37.50 |
| AVG Volume (30 Days) | ★ 526.9K | 250.0K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | N/A | ★ 51.72 |
| EPS | ★ 2.35 | 1.27 |
| Revenue | N/A | ★ $152,188,000.00 |
| Revenue This Year | $874.25 | N/A |
| Revenue Next Year | N/A | $3.22 |
| P/E Ratio | $58.44 | ★ $30.20 |
| Revenue Growth | N/A | ★ 15.52 |
| 52 Week Low | $62.24 | $30.78 |
| 52 Week High | $160.81 | $40.41 |
Technical Indicators
Market Signals| Indicator | PTGX | HTH |
|---|---|---|
| Relative Strength Index (RSI) | 46.76 | 49.98 |
| Support Level | $141.95 | $38.34 |
| Resistance Level | $151.24 | $39.68 |
| Average True Range (ATR) | 5.11 | 0.60 |
| MACD | -0.89 | -0.02 |
| Stochastic Oscillator | 48.37 | 49.61 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The company has three segments: The banking segment includes the operations of the Bank; The broker-dealer segment includes the operations of Securities Holdings,; and the mortgage origination segment is composed of PrimeLending. Majority of revenue is from Broker-dealer Segment.